These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10640588)

  • 41. Localized delivery of paclitaxel using elastic liposomes: formulation development and evaluation.
    Utreja P; Jain S; Tiwary AK
    Drug Deliv; 2011 Jul; 18(5):367-76. PubMed ID: 21428706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antitumor activity of paclitaxel-2'-glycinate conjugated to poly(ethylene glycol): a water-soluble prodrug.
    Pendri A; Conover CD; Greenwald RB
    Anticancer Drug Des; 1998 Jul; 13(5):387-95. PubMed ID: 9702205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation and in vitro evaluation of amphiphilic paclitaxel small molecule prodrugs and enhancement of oral absorption.
    Li Y; Yang M; Zhao Y; Li L; Xu W
    Eur J Med Chem; 2021 Apr; 215():113276. PubMed ID: 33611186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
    Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H
    Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ethanol-based proliposome delivery systems of paclitaxel for in vitro application against brain cancer cells.
    Najlah M; Jain M; Wan KW; Ahmed W; Albed Alhnan M; Phoenix DA; Taylor KMG; Elhissi A
    J Liposome Res; 2018 Mar; 28(1):74-85. PubMed ID: 27834116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and toxicological studies of cremophor EL free alternative paclitaxel formulation.
    Utreja P; Jain S; Yadav S; Khandhuja KL; Tiwary AK
    Curr Drug Saf; 2011 Nov; 6(5):329-38. PubMed ID: 22424541
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy.
    Kim SC; Kim DW; Shim YH; Bang JS; Oh HS; Wan Kim S; Seo MH
    J Control Release; 2001 May; 72(1-3):191-202. PubMed ID: 11389998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells.
    Lv Y; Xu C; Zhao X; Lin C; Yang X; Xin X; Zhang L; Qin C; Han X; Yang L; He W; Yin L
    ACS Nano; 2018 Feb; 12(2):1519-1536. PubMed ID: 29350904
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and preclinical characterization of a paclitaxel prodrug with improved antitumor activity and water solubility.
    Niethammer A; Gaedicke G; Lode HN; Wrasidlo W
    Bioconjug Chem; 2001; 12(3):414-20. PubMed ID: 11353540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer.
    Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J
    Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The enhanced longevity and liver targetability of Paclitaxel by hybrid liposomes encapsulating Paclitaxel-conjugated gold nanoparticles.
    Bao QY; Zhang N; Geng DD; Xue JW; Merritt M; Zhang C; Ding Y
    Int J Pharm; 2014 Dec; 477(1-2):408-15. PubMed ID: 25455782
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug delivery systems: water soluble taxol 2'-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness.
    Greenwald RB; Gilbert CW; Pendri A; Conover CD; Xia J; Martinez A
    J Med Chem; 1996 Jan; 39(2):424-31. PubMed ID: 8558510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A folate receptor-targeted liposomal formulation for paclitaxel.
    Wu J; Liu Q; Lee RJ
    Int J Pharm; 2006 Jun; 316(1-2):148-53. PubMed ID: 16564654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A mixed micellar formulation suitable for the parenteral administration of taxol.
    Alkan-Onyuksel H; Ramakrishnan S; Chai HB; Pezzuto JM
    Pharm Res; 1994 Feb; 11(2):206-12. PubMed ID: 7909371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activity of paclitaxel liposome formulations against human ovarian tumor xenografts.
    Sharma A; Mayhew E; Bolcsak L; Cavanaugh C; Harmon P; Janoff A; Bernacki RJ
    Int J Cancer; 1997 Mar; 71(1):103-7. PubMed ID: 9096672
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: an in vitro and in vivo evaluation study.
    Elsadek B; Graeser R; Esser N; Schäfer-Obodozie C; Abu Ajaj K; Unger C; Warnecke A; Saleem T; El-Melegy N; Madkor H; Kratz F
    Eur J Cancer; 2010 Dec; 46(18):3434-44. PubMed ID: 20933385
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
    Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S
    J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigation of the antitumor activity and toxicity of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in a murine breast cancer animal model.
    Franco MS; Roque MC; de Barros ALB; de Oliveira Silva J; Cassali GD; Oliveira MC
    Biomed Pharmacother; 2019 Jan; 109():1728-1739. PubMed ID: 30551427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemia.
    Sharma A; Sharma US; Straubinger RM
    Cancer Lett; 1996 Oct; 107(2):265-72. PubMed ID: 8947523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Paclitaxel pharmacodynamics: application of a mechanism-based neutropenia model.
    Fetterly GJ; Tamburlin JM; Straubinger RM
    Biopharm Drug Dispos; 2001 Sep; 22(6):251-61. PubMed ID: 11754041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.